Y-Intercept (HK)’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.6M Buy
563,311
+482,960
+601% +$7.21M 0.1% 257
2026
Q2
$1.91M Buy
+80,351
New +$1.54M 0.04% 733
2026
Q1
– Sell
-262,525
Closed -$5.18M – 1516
2025
Q4
$5.18M Buy
262,525
+62,036
+31% +$1.11M 0.12% 221
2025
Q3
$3.5M Buy
+200,489
New +$2.97M 0.08% 341
2025
Q2
– Sell
-61,154
Closed -$1.14M – 1608
2025
Q1
$1.14M Buy
+61,154
New +$912K 0.08% 360
2024
Q4
– Sell
-44,218
Closed -$523K – 1143
2024
Q3
$523K Buy
+44,218
New +$418K 0.03% 752
2023
Q4
– Sell
-15,856
Closed -$110K – 1194
2023
Q3
$110K Sell
15,856
-10,475
-40% -$63.2K 0.01% 963
2023
Q2
$151K Buy
26,331
+7,237
+38% +$46.8K 0.02% 985
2023
Q1
$121K Buy
+19,094
New +$182K 0.01% 1032

Other funds holding ALHC

Y-Intercept (HK)'s ALHC Position: Q3 2026 in Review

Y-Intercept (HK) increased its Alignment Healthcare (ALHC) stake by 601% in Q3 2026, buying an estimated $7.21M and bringing the position to 563,311 shares worth $4.6M. The position accounts for 0.1% of the portfolio, ranked #257.

Y-Intercept (HK) first reported a position in ALHC in Q1 2023 and has held it in 9 quarters since. The position peaked at $5.18M in Q4 2025. 81 funds tracked by Wall St. Rank hold ALHC as of Q3 2026.

  • Y-Intercept (HK) held 563,311 shares of Alignment Healthcare worth $4.6M as of Q3 2026.
  • Y-Intercept (HK) bought 482,960 Alignment Healthcare shares in Q3 2026, an estimated $7.21M.
  • Alignment Healthcare made up 0.1% of Y-Intercept (HK)'s portfolio in Q3 2026, its #257 holding.
  • Y-Intercept (HK) first reported a position in Alignment Healthcare in Q1 2023 and has held it in 9 quarters since.
  • Y-Intercept (HK)'s Alignment Healthcare position peaked at $5.18M in Q4 2025.
  • 81 funds tracked by Wall St. Rank held Alignment Healthcare as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.